Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.
Oct 19, 2025
1
247
The first-in-class YAP-TEAD inhibitor VT3989 continued to be well tolerated and demonstrated notable initial antitumor activity, particularly in patients with refractory mesothelioma, according to results from a trial led ...
Oct 19, 2025
0
14
Ibuprofen is a household name—the go-to remedy for everything from headaches to period pain. But recent research suggests this everyday drug might be doing more than easing discomfort. It could also have anti-cancer properties.
Oct 19, 2025
0
23
Increasing social media usage among children has been linked to a decline in cognitive performance. A JAMA study involving 6,554 adolescents aged 9–13 found that those who spent more time on social media scored lower in ...
A new 3D human brain tissue platform developed by MIT researchers is the first to integrate all major brain cell types, including neurons, glial cells and the vasculature into a single culture. Grown from individual donors' ...
Oct 18, 2025
0
121
Nurse Rod Salaysay works with all kinds of instruments in the hospital: a thermometer, a stethoscope and sometimes his guitar and ukulele.
Oct 18, 2025
1
74
Malaria remains one of the leading causes of death among children in sub-Saharan Africa, claiming more than 600,000 lives each year worldwide with limited efficacy in currently available treatments and vaccines. Now a new ...
Oct 18, 2025
0
46
When a child falls ill, caregivers often change how and where the infant sleeps—wanting to keep them close through the night. But new research from Johns Hopkins Children's Center suggests that some of these changes—although ...
Oct 18, 2025
0
0
Vegetable oils are everywhere, and almost everyone has an opinion about them. From clever marketing in supermarket aisles to headlines about deforestation, they have become both the heroes and villains of the modern diet. ...
Oct 18, 2025
0
2
Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...
Oct 18, 2025
0
0
